Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV
Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV

NCT03296202

Active Not RecruitingN/A

Sponsor: University Hospital, Bordeaux

Conditions: HIV Infections, Antiretroviral Agents

Countries: France

HIV infection is now a chronic disease in countries where antiretroviral treatments (ART) are largely available. Long-term follow-up is required to describe and understand the evolution of morbidities and complications as well as new treatments side effects. The main objective of the cohort is to describe and study the evolution of HIV infection in ART-treated individuals.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Patients aged over 18 years old.
* Confirmed HIV infection
* Signed informed consent

Exclusion Criteria:

* HIV-2 infection
Locations (19)
  • Agen, France
  • Angoulême, France
  • Bayonne, France
  • Bordeaux, France
  • Bordeaux, France
  • Bordeaux, France
  • Bordeaux, France
  • Dax, France
  • Jonzac, France
  • La Teste-de-Buch, France
  • Libourne, France
  • Orthez, France
  • Pau, France
  • Pessac, France
  • Périgueux, France
  • Poitiers, France
  • Royan, France
  • Saint-Jean-d'Angély, France
  • Saintes, France